| Description |
1 online resource (xvii, 320 pages) |
| Series |
RSC drug discovery series ; 42 |
|
RSC drug discovery series ; 42.
|
| Contents |
Venomous animals: evolution and ecology; Chemistry and structural biology of animal venoms; Venoms-based drug discovery: proteomic and transcriptomic approaches; Venoms-based drug discovery: bioassays, high-throughput screens, and target identification; Reptile venoms as a platform for drug development; Cone snail venoms as a platform for drug development; Scorpion venoms as a platform for drug development; Spider-venom peptides as a platform for drug development; Case study 1: development of the analgesic drugs Prialt® and Xen2174; Case study 2: development of exenatide for treatment of type 2 diabetes; Case study 3: development of ShK for the treatment of autoimmune diseases; Development of venom natriuretic peptides for treating congestive heart failure; Engineering venom peptides to improve their stability and bioavailability; Manufacturing of venom-derived therapeutic peptides; Venoms to drugs: prospects and pitfalls |
| Summary |
A comprehensive and up-to-date review on the potential of peptides and proteins from animal venoms as human therapeutics |
| Bibliography |
Includes bibliographical references and index |
| Notes |
Online resource; title from digital title page (viewed on March 03, 2015) |
| Subject |
Venom -- Therapeutic use
|
|
Drug development.
|
|
Peptide drugs.
|
|
Pharmaceutical biotechnology.
|
|
Venoms -- therapeutic use
|
|
Therapy & therapeutics.
|
|
MEDICAL -- Pharmacology.
|
|
Peptide drugs
|
|
Drug development
|
|
Pharmaceutical biotechnology
|
|
Venom -- Therapeutic use
|
| Form |
Electronic book
|
| Author |
King, Glenn F., editor
|
| ISBN |
9781849737876 |
|
1849737878 |
|
9781782624370 |
|
1782624376 |
|
1849736634 |
|
9781849736633 |
|
